Filter
3855
Filtered Results: 3855
Text search:
medicines
control
act
Featured
Recommendations
409
New Publications
1110
Language
Document type
No document type
2052
Studies & Reports
653
Guidelines
552
Manuals
213
Strategic & Response Plan
178
Fact sheets
71
Training Material
59
Situation Updates
40
Brochures
14
Infographics
10
Resource Platforms
9
Online Courses
4
Countries / Regions
India
204
Global
166
Kenya
132
Ethiopia
99
South Africa
97
Uganda
88
Sierra Leone
83
Liberia
80
Nigeria
79
Africa
76
Western and Central Europe
75
Nepal
71
Ghana
68
Tanzania
68
Malawi
59
Zambia
57
Bangladesh
55
Myanmar / Burma
53
Rwanda
50
Ukraine
49
Latin America and the Carribbean
49
Namibia
43
Philippines
38
Syria
37
Congo, Democratic Republic of
35
Eastern Europe
31
Zimbabwe
30
South–East Asia Region
30
Mozambique
26
Haiti
25
Asia
25
Venezuela
24
Guinea
21
Cambodia
20
Lesotho
20
Middle East and North Africa
20
Indonesia
19
West and Central Africa
19
Senegal
18
South Sudan
17
East and Southern Africa
17
Botswana
16
Russia
16
Burkina Faso
15
Madagascar
15
Yemen
15
Eswatini/ Swaziland
13
Eastern Europe and Central Asia
13
Pakistan
11
Sudan
11
Brazil
11
Cameroon
10
Somalia
10
Afghanistan
10
Western Pacific Region
10
Colombia
9
Thailand
8
Germany
7
Lebanon
7
Benin
7
Moldova
7
Vietnam
7
North America
7
Jordan
6
Central African Republic
6
Tajikistan
6
Georgia
6
Mali
5
Iraq
5
Argentina
5
North Macedonia
5
Paraguay
5
Palestine
5
Albania
5
Laos
5
China
4
Peru
4
Hungary
4
Bolivia
4
Mexico
4
Poland
4
Côte d’Ivoire / Ivory Coast
3
Morocco
3
USA
3
Saudi Arabia
3
Niger
3
Egypt
3
Papua New Guinea
3
Ecuador
3
El Salvador
3
Libya
3
Angola
3
Bhutan
3
Southern Africa
3
Iran
3
Kyrgyzstan
3
Jamaica
3
Mauritius
3
Guinea-Bissau
2
Turkey
2
Chad
2
Serbia
2
Sri Lanka
2
Chile
2
Fiji
2
Armenia
2
Canada
2
Timor Leste/ East Timor
2
Qatar
2
Bulgaria
2
Romania
2
Kazakhstan
2
Gabon
2
Turkmenistan
2
Japan
2
Tunisia
2
United Kingdom
2
Belarus
2
Togo
1
Gambia
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Nicaragua
1
Other region
1
Djibouti
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1602
Clinical Guidelines
361
Public Health
255
Women & Child Health
154
Key Resources
98
Capacity Building
55
Pharmacy & Technologies
41
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
COVID-19
294
HIV
286
TB
261
AMR
248
Mental Health
211
Pharmacy
164
NCDs
123
Caregiver
105
Ebola
90
Rapid Response
88
Conflict
85
Planetary Health
79
NTDs
79
Disability
66
Global Health Education
62
Refugee
57
Health Financing Toolbox
34
Natural Hazards
30
Zika
16
Cholera
14
Polio
12
Specific Hazards
10
Social Ethics
6
Health Financing
2
Typhoon
1
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical .... Through the Global Action Plan on AMR, WHO is working to improve the surveillance of antimicrobial resistance and reduce inappropriate antibiotic consumption.
There is a recognized need for high-quality resources to improve antibiotic prescribing globally. To address this need, a pragmatic approach was taken by WHO to develop actionable guidance for empiric antibiotic use.
The WHO AWaRe (Access, Watch, Reserve) antibiotic book provides concise, evidence-based guidance on the choice of antibiotic, dose, route of administration, and duration of treatment for more than 30 of the most common clinical infections in children and adults in both primary health care and hospital settings. The information included in the book supports the recommendations for antibiotics listed on the WHO Model Lists of Essential Medicines and Essential Medicines Children and the WHO AWaRe classification of antibiotics.
The WHO AWaRe antibiotic book is accompanied by summary infographics for each infection for both adults and children that provide a quick-reference guide for health care workers at the point of care.
Accessed on 31.03.2023
COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Dise...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps....
The aim of the framework is to provide guidance to Member States and partners on region-specific priority actions towards the goals, targets and milestones of the GTS. The central pillar of the framework is the adoption of programme phasing and tran...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority ...ions for attaining the targets. The 2010 baseline estimates on NCD mortality and risk factors are provided so that countries can report on progress, starting in 2015. In addition, the report also provides the latest available estimates on NCD mortality (2012) and risk factors, 2010-2012.All ministries of health need to set national NCD targets and lead the development and implementation of policies and interventions to attain them. There is no single pathway to attain NCD targets that fits all countries, as they are at different points in their progress in the prevention and control of NCDs and at different levels of socioeconomic development. However all countries can benefit from the comprehensive response to attaining the voluntary global targets presented in this report.
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from ... commonly used to cure Plasmodium vivax malaria, as well as from other medicines and substances.
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of ...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities...
After years of relative calm, Zimbabwe has been grappling with a cholera outbreak since 12 February 2023. This resurgence is not an isolated incident, as 10 more countries (Malawi, Mozambique, Somalia, Kenya, Ethiopia, Zambia, South Sudan, Burundi, Tanzania and South Africa) in Eastern and Southern ...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term ...
The term ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop...
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includesmeasures to prevent and ... infection that can stop people needing antimicrobials or spreadinginfection to others. It aims to change people's behaviour to reduce antimicrobial resistance and thespread of resistant microbes.
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human ...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at si...
Health care waste management (HCWM) and infection prevention and control (IPC) represent serious concerns for HIV programs. Improperly handled infectious health care waste poses risks to health workers, their clients, the community, and the environm...
Asthma can be a serious disease, but if you understand
the disease and take the right medication to control it, you
should have no problems or symptoms due to your asthma,
even when you are pregnant. To be free from asthma
attacks, you should al...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in develop...
